Total Payments
$272,305
2024 Payments
$44,519
Companies
22
Transactions
307
Medicare Patients
1,243
Medicare Billing
$174,841
Payment Breakdown by Category
Other$198,723 (73.0%)
Consulting$35,673 (13.1%)
Travel$29,739 (10.9%)
Food & Beverage$7,768 (2.9%)
Education$402.47 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $194,433 | 57 | 71.4% |
| Consulting Fee | $35,673 | 14 | 13.1% |
| Travel and Lodging | $29,739 | 97 | 10.9% |
| Food and Beverage | $7,768 | 129 | 2.9% |
| Honoraria | $4,290 | 1 | 1.6% |
| Education | $402.47 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $207,930 | 196 | $0 (2024) |
| Genentech USA, Inc. | $50,768 | 36 | $0 (2024) |
| CSL Behring | $5,243 | 12 | $0 (2023) |
| Grifols USA, LLC | $2,755 | 11 | $0 (2023) |
| Genentech, Inc. | $2,687 | 14 | $0 (2024) |
| F. Hoffmann-La Roche AG | $1,272 | 3 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $760.99 | 11 | $0 (2024) |
| UCB, Inc. | $192.77 | 3 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $143.04 | 2 | $0 (2018) |
| Alnylam Pharmaceuticals Inc. | $122.97 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44,519 | 49 | Biogen, Inc. ($31,323) |
| 2023 | $52,707 | 67 | Genentech USA, Inc. ($23,968) |
| 2022 | $72,736 | 82 | Biogen, Inc. ($56,668) |
| 2021 | $22,958 | 17 | Biogen, Inc. ($22,883) |
| 2020 | $20,024 | 11 | Biogen, Inc. ($19,995) |
| 2019 | $57,707 | 63 | Biogen, Inc. ($52,612) |
| 2018 | $1,202 | 13 | Biogen, Inc. ($420.78) |
| 2017 | $452.14 | 5 | Biogen, Inc. ($241.54) |
All Payment Transactions
307 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Genentech USA, Inc. | Evrysdi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,830.00 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/18/2024 | Biogen, Inc. | SPINRAZA (Biological) | Consulting Fee | Cash or cash equivalent | $4,110.00 | General |
| Category: Neurology | ||||||
| 12/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $33.57 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Genentech USA, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $90.96 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Neuroscience | ||||||
| 11/29/2024 | Genentech USA, Inc. | Evrysdi (Drug) | Travel and Lodging | Cash or cash equivalent | $199.66 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Genentech USA, Inc. | Evrysdi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,520.00 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Biogen, Inc. | SPINRAZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,425.00 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Genentech USA, Inc. | Evrysdi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Neurology | ||||||
| 11/13/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: Rare Disease | ||||||
| 11/06/2024 | Biogen, Inc. | SPINRAZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,110.00 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $121.80 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: EPILEPSY | ||||||
| 11/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Rare Disease | ||||||
| 10/31/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Neurology | ||||||
| 10/05/2024 | Genentech USA, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $35.51 | General |
| Category: Neurology | ||||||
| 09/13/2024 | Biogen, Inc. | SPINRAZA (Biological) | Travel and Lodging | Cash or cash equivalent | $113.00 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Biogen, Inc. | SPINRAZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,220.00 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Biogen, Inc. | SPINRAZA (Biological) | Travel and Lodging | In-kind items and services | $345.00 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Biogen, Inc. | SPINRAZA (Biological) | Travel and Lodging | Cash or cash equivalent | $100.00 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $98.63 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Biogen, Inc. | SPINRAZA (Biological) | Travel and Lodging | Cash or cash equivalent | $46.00 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 293 | 380 | $228,853 | $41,516 |
| 2022 | 7 | 306 | 417 | $259,543 | $45,750 |
| 2021 | 11 | 265 | 331 | $202,238 | $41,536 |
| 2020 | 13 | 379 | 454 | $242,129 | $46,039 |
Total Patients
1,243
Total Services
1,582
Medicare Billing
$174,841
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 137 | $78,638 | $14,194 | 18.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 72 | 122 | $57,125 | $10,708 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $19,527 | $4,099 | 21.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 20 | 20 | $21,620 | $3,842 | 17.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 25 | 25 | $17,225 | $2,948 | 17.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 21 | 21 | $19,110 | $2,869 | 15.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $9,588 | $1,852 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 14 | $6,020 | $1,005 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 163 | $93,562 | $15,866 | 17.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 64 | 113 | $53,449 | $10,016 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $31,038 | $5,516 | 17.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 36 | $28,764 | $5,011 | 17.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 27 | 28 | $25,480 | $4,418 | 17.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 24 | 24 | $16,536 | $2,986 | 18.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $10,714 | $1,937 | 18.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 86 | 120 | $63,300 | $13,292 | 21.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 41 | 65 | $29,833 | $6,165 | 20.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 27 | $19,023 | $4,361 | 22.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $16,887 | $3,377 | 20.0% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 18 | 18 | $16,380 | $3,096 | 18.9% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 14 | 14 | $15,134 | $2,924 | 19.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $11,108 | $2,364 | 21.3% |
| 95924 | Testing of autonomic (sympathetic) nervous system function, at least 5 minutes of tilt | Office | 2021 | 13 | 13 | $9,061 | $1,807 | 19.9% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 13 | 13 | $8,957 | $1,727 | 19.3% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2021 | 13 | 13 | $8,606 | $1,601 | 18.6% |
About Dr. Manisha Korb, M.D
Dr. Manisha Korb, M.D is a Neuromuscular Medicine healthcare provider based in West Palm Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2012. The National Provider Identifier (NPI) number assigned to this provider is 1235494089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manisha Korb, M.D has received a total of $272,305 in payments from pharmaceutical and medical device companies, with $44,519 received in 2024. These payments were reported across 307 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($194,433).
As a Medicare-enrolled provider, Korb has provided services to 1,243 Medicare beneficiaries, totaling 1,582 services with total Medicare billing of $174,841. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuromuscular Medicine
- Location West Palm Beach, FL
- Active Since 07/09/2012
- Last Updated 09/04/2024
- Taxonomy Code 2084N0008X
- Entity Type Individual
- NPI Number 1235494089
Products in Payments
- SPINRAZA (Biological) $183,969
- Evrysdi (Drug) $51,532
- Spinraza (Biological) $23,499
- Hizentra (Biological) $5,243
- Gamunex-C (Biological) $2,812
- SOLIRIS (Drug) $441.16
- Briviact (Drug) $192.77
- ULTOMIRIS (Biological) $162.11
- QALSODY (Drug) $151.10
- NUEDEXTA (Drug) $143.04
- SOLIRIS (Biological) $128.82
- AMVUTTRA (Drug) $109.84
- DISEASE STATE (Drug) $100.73
- VYVGART (Drug) $62.24
- Xeomin (Biological) $55.94
- Elevidys (Drug) $32.05
- Soliris (Drug) $28.90
- RADICAVA (Drug) $20.74
- Ocrevus Zunovo (Biological) $20.38
- NORTHERA (Drug) $20.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.